REG - RUA Life Sciences - Result of AGM

Rua Life SciencesAnnouncement

11/08/2020 12:05

RNS Number : 8103V
  
RUA Life Sciences PLC
  
11 August 2020
  
 

 
  
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Result of AGM
RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM), announces that all resolutions put to shareholders at its Annual General Meeting held earlier today, were duly passed.
 
For further information contact:
 
RUA Life Sciences
Bill Brown, Chairman                       Tel: +44 (0) 77 3071 8296                                   
David Richmond, CEO                     Tel: +44(0) 78 9999 6400
 
Shore Capital                                                             
Tom Griffiths/David Coaten              Tel: +44 (0)20 7408 4080
 
 
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when RUA Life Sciences Plc (formerly known as AorTech International Plc) acquired RUA Medical Devices Limited to create a fully formed medical device business. RUA Life Sciences is the holding company of the Group's four trading businesses, each exploiting the Group's patented polymer technology.
Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the world's leading long-term implantable polyurethane.
Whether it is licensing Elast-EonTM, manufacturing a device or component or developing next generation medical devices, a RUA Life Sciences business is pursuing our vision.
 
Elast-Eon™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. With over 7 million implants and over 14 years of successful clinical use, RUA's polymers are proven in long-term life enabling applications.
 
The Group's four business units are:




RUA Medical:


End-to-end contract developer and manufacturer of medical devices and implantable fabric specialist.




RUA Biomaterials:


Licensor of Elast-EonTM polymers to the medical device industry.




RUA Vascular:


Commercialisation of large bore polymer sealed grafts and soft tissue patches.




RUA Structural Heart:


Development of tri leaflet polymeric heart valves.




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
RAGPBMBTMTMBBTM